PMID- 25744394 OWN - NLM STAT- MEDLINE DCOM- 20150609 LR - 20220408 IS - 1879-0631 (Electronic) IS - 0024-3205 (Linking) VI - 127 DP - 2015 Apr 15 TI - Involvement of TLR2 and TLR9 in the anti-inflammatory effects of chlorogenic acid in HSV-1-infected microglia. PG - 12-8 LID - S0024-3205(15)00105-8 [pii] LID - 10.1016/j.lfs.2015.01.036 [doi] AB - AIMS: There is no effective medication to date for herpes simplex virus encephalitis (HSE). In this study, we investigated the anti-inflammatory effect of chlorogenic acid (CGA) on herpes simplex virus (HSV)-1-induced responses in BV2 microglia. MAIN METHODS: The cellular model was established with BV2 cells stimulated by HSV-1 and then treated with CGA at different concentrations. Cell viability was assayed by the MTT assay. The mRNA expression of Toll-like receptor (TLR)-2, TLR9 and myeloid differentiation factor88 (Myd88) was assayed by real-time quantitative PCR, and the protein expression was assayed by flow cytometry or Western blotting. Tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-6 were measured by ELISA as well as real-time quantitative PCR. Nuclear NF-kappaB p65 protein was assayed by Western blotting. KEY FINDINGS: The cell survival rate was significantly improved after CGA treatment, and CGA prevented increases in TLR2, TLR9 and Myd88 following HSV-1 challenge in BV2 cells both at the mRNA and protein levels. Moreover, CGA could attenuate HSV-induced TNF-alpha and IL-6 release into the supernatant. The mRNA levels of TNF-alpha and IL-6 were also significantly inhibited by CGA. The expression of NF-kappaB p65 increased significantly in the nucleus in HSV-1-stimulated microglia but could be reduced by CGA. SIGNIFICANCE: CGA inhibits the inflammatory reaction in HSE via the suppression of TLR2/TLR9-Myd88 signaling pathways. CGA may serve as an anti-inflammatory agent and provide a new strategy for treating HSE. CI - Copyright (c) 2015 Elsevier Inc. All rights reserved. FAU - Guo, Yuan-Jin AU - Guo YJ AD - Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China. FAU - Luo, Tao AU - Luo T AD - Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China; Department of Neurology, Wuhan Central Hospital, Wuhan 430014, PR China. FAU - Wu, Fei AU - Wu F AD - Department of Neurology, Wuhan General Hospital of Guangzhou Military Command, Wuhan 430070, PR China. FAU - Mei, Yuan-Wu AU - Mei YW AD - Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China. FAU - Peng, Jun AU - Peng J AD - Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China. FAU - Liu, Huan AU - Liu H AD - Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China. FAU - Li, Hua-Rong AU - Li HR AD - Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China. FAU - Zhang, Shu-Ling AU - Zhang SL AD - Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China. FAU - Dong, Ji-Hua AU - Dong JH AD - Central Lab, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China. FAU - Fang, Yuan AU - Fang Y AD - Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China. FAU - Zhao, Lei AU - Zhao L AD - Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China. Electronic address: leizhao@hust.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150302 PL - Netherlands TA - Life Sci JT - Life sciences JID - 0375521 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Cytokines) RN - 0 (Interleukin-6) RN - 0 (NF-kappa B) RN - 0 (Toll-Like Receptor 2) RN - 0 (Toll-Like Receptor 9) RN - 0 (Tumor Necrosis Factor-alpha) RN - 318ADP12RI (Chlorogenic Acid) SB - IM MH - Anti-Inflammatory Agents/*pharmacology MH - Cell Line MH - Cell Survival/drug effects MH - Chlorogenic Acid/*pharmacology MH - Cytokines/metabolism MH - Herpes Simplex/*pathology/virology MH - *Herpesvirus 1, Human MH - Humans MH - Interleukin-6/metabolism MH - Microglia/*drug effects MH - NF-kappa B/drug effects/metabolism MH - Signal Transduction/drug effects MH - Toll-Like Receptor 2/biosynthesis/*drug effects MH - Toll-Like Receptor 9/biosynthesis/*drug effects MH - Tumor Necrosis Factor-alpha/metabolism OTO - NOTNLM OT - Chlorogenic acid OT - Herpes simplex virus-1 OT - Inflammation OT - Toll-like receptor 2 OT - Toll-like receptor 9 EDAT- 2015/03/10 06:00 MHDA- 2015/06/10 06:00 CRDT- 2015/03/07 06:00 PHST- 2014/08/11 00:00 [received] PHST- 2015/01/29 00:00 [revised] PHST- 2015/01/30 00:00 [accepted] PHST- 2015/03/07 06:00 [entrez] PHST- 2015/03/10 06:00 [pubmed] PHST- 2015/06/10 06:00 [medline] AID - S0024-3205(15)00105-8 [pii] AID - 10.1016/j.lfs.2015.01.036 [doi] PST - ppublish SO - Life Sci. 2015 Apr 15;127:12-8. doi: 10.1016/j.lfs.2015.01.036. Epub 2015 Mar 2.